{"id":"https://openalex.org/W2012171192","doi":"https://doi.org/10.1002/glia.20250","title":"Dopamine D2 and D3 receptor agonists limit oligodendrocyte injury caused by glutamate oxidative stress and oxygen/glucose deprivation","display_name":"Dopamine D2 and D3 receptor agonists limit oligodendrocyte injury caused by glutamate oxidative stress and oxygen/glucose deprivation","alternate_titles":[],"publication_year":2005,"publication_date":"2005-08-02","ids":{"openalex":"https://openalex.org/W2012171192","doi":"https://doi.org/10.1002/glia.20250","mag":"2012171192","pmid":"https://pubmed.ncbi.nlm.nih.gov/16078234"},"language":"en","primary_location":{"id":"doi:10.1002/glia.20250","doi":"https://doi.org/10.1002/glia.20250","is_oa":false,"landing_page_url":"https://doi.org/10.1002/glia.20250","pdf_url":null,"source":{"id":"https://openalex.org/S147407642","display_name":"Glia","issn_l":"0894-1491","issn":["0894-1491","1098-1136"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Glia","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2012171192"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://figshare.com/articles/journal_contribution/Dopamine_D2_and_D3_receptor_agonists_limit_oligodendrocyte_injury_caused_by_glutamate_oxidative_stress_and_oxygen_glucose_deprivation/24399754","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088983266","display_name":"Claudia Rosin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Claudia Rosin","raw_affiliation_strings":["Neurology and GI Centre of Excellence for Drug Discovery, GlaxoSmithKline Research and Development Limited, Harlow, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology and GI Centre of Excellence for Drug Discovery, GlaxoSmithKline Research and Development Limited, Harlow, United Kingdom","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031373492","display_name":"Sergio L. Colombo","orcid":"https://orcid.org/0000-0001-7360-986X","observed_orcids":["https://orcid.org/0000-0001-7360-986X"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sergio Colombo","raw_affiliation_strings":["Neurology and GI Centre of Excellence for Drug Discovery, GlaxoSmithKline Research and Development Limited, Harlow, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology and GI Centre of Excellence for Drug Discovery, GlaxoSmithKline Research and Development Limited, Harlow, United Kingdom","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000338259","display_name":"Andrew R. Calver","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andrew A. Calver","raw_affiliation_strings":["Neurology and GI Centre of Excellence for Drug Discovery, GlaxoSmithKline Research and Development Limited, Harlow, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology and GI Centre of Excellence for Drug Discovery, GlaxoSmithKline Research and Development Limited, Harlow, United Kingdom","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016617654","display_name":"Timothy Edward Bates","orcid":"https://orcid.org/0000-0001-5955-0259","observed_orcids":["https://orcid.org/0000-0001-5955-0259"]},"institutions":[{"id":"https://openalex.org/I142263535","display_name":"University of Nottingham","ror":"https://ror.org/01ee9ar58","country_code":"GB","type":"education","lineage":["https://openalex.org/I142263535"]},{"id":"https://openalex.org/I4210137227","display_name":"Queen's Medical Centre","ror":"https://ror.org/03ap6wx93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1334287468","https://openalex.org/I4210137227"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Timothy E. Bates","raw_affiliation_strings":["School of Biomedical Sciences, University of Nottingham, Medical School, Queen\u2019s Medical Centre, Nottingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Biomedical Sciences, University of Nottingham, Medical School, Queen\u2019s Medical Centre, Nottingham, United Kingdom","institution_ids":["https://openalex.org/I142263535","https://openalex.org/I4210137227"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006221519","display_name":"Stephen D. Skaper","orcid":"https://orcid.org/0000-0001-5012-9660","observed_orcids":["https://orcid.org/0000-0001-5012-9660"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Stephen D. Skaper","raw_affiliation_strings":["Neurology and GI Centre of Excellence for Drug Discovery, GlaxoSmithKline Research and Development Limited, Harlow, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology and GI Centre of Excellence for Drug Discovery, GlaxoSmithKline Research and Development Limited, Harlow, United Kingdom","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4405268060"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5006221519"],"corresponding_institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4405268060"],"apc_list":{"value":5450,"currency":"USD","value_usd":5450},"apc_paid":null,"fwci":1.0642,"has_fulltext":false,"cited_by_count":85,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.70320464,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"52","issue":"4","first_page":"336","last_page":"343"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.43290001153945923,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.43290001153945923,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.14139999449253082,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.1356000006198883,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dopamine-d2-receptor","display_name":"dopamine D2 receptor","score":0.9869999885559082},{"id":"https://openalex.org/keywords/dopamine-d3-receptor","display_name":"dopamine D3 receptor","score":1.0},{"id":"https://openalex.org/keywords/dopamine-agonists","display_name":"dopamine agonists","score":0.8989999890327454},{"id":"https://openalex.org/keywords/oligodendrocytes","display_name":"oligodendrocytes","score":0.925000011920929},{"id":"https://openalex.org/keywords/oxygen-glucose-deprivation","display_name":"oxygen-glucose deprivation","score":0.8759999871253967},{"id":"https://openalex.org/keywords/white-matter-injury","display_name":"white matter injury","score":0.8259999752044678},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9890000224113464},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.7289999723434448},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9789999723434448},{"id":"https://openalex.org/keywords/receptor-antagonists","display_name":"receptor antagonists","score":0.6389999985694885}],"concepts":[{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.7641149759292603},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.63947993516922},{"id":"https://openalex.org/C2776985911","wikidata":"https://www.wikidata.org/wiki/Q916698","display_name":"Oligodendrocyte","level":4,"score":0.571370542049408},{"id":"https://openalex.org/C199596767","wikidata":"https://www.wikidata.org/wiki/Q21110872","display_name":"Dopamine receptor D3","level":4,"score":0.5701953172683716},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5659613609313965},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.5481678247451782},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5320020318031311},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5189128518104553},{"id":"https://openalex.org/C120069818","wikidata":"https://www.wikidata.org/wiki/Q415496","display_name":"Dopamine receptor","level":3,"score":0.5087695717811584},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.4769236743450165},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.44204720854759216},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.44088345766067505},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.30270886421203613},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.16817599534988403},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.15412035584449768},{"id":"https://openalex.org/C2778609137","wikidata":"https://www.wikidata.org/wiki/Q105790271","display_name":"Myelin","level":3,"score":0.12182626128196716}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005947","descriptor_name":"Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009836","descriptor_name":"Oligodendroglia","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009836","descriptor_name":"Oligodendroglia","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D010100","descriptor_name":"Oxygen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011954","descriptor_name":"Receptors, Dopamine","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D011954","descriptor_name":"Receptors, Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016923","descriptor_name":"Cell Death","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016923","descriptor_name":"Cell Death","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017448","descriptor_name":"Receptors, Dopamine D2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D017448","descriptor_name":"Receptors, Dopamine D2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018384","descriptor_name":"Oxidative Stress","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018384","descriptor_name":"Oxidative Stress","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D018491","descriptor_name":"Dopamine Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018492","descriptor_name":"Dopamine Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018698","descriptor_name":"Glutamic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D020925","descriptor_name":"Hypoxia-Ischemia, Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D020925","descriptor_name":"Hypoxia-Ischemia, Brain","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D020925","descriptor_name":"Hypoxia-Ischemia, Brain","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D050637","descriptor_name":"Receptors, Dopamine D3","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D050637","descriptor_name":"Receptors, Dopamine D3","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1002/glia.20250","doi":"https://doi.org/10.1002/glia.20250","is_oa":false,"landing_page_url":"https://doi.org/10.1002/glia.20250","pdf_url":null,"source":{"id":"https://openalex.org/S147407642","display_name":"Glia","issn_l":"0894-1491","issn":["0894-1491","1098-1136"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Glia","raw_type":"journal-article"},{"id":"pmid:16078234","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16078234","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Glia","raw_type":"Journal Article"},{"id":"pmh:oai:figshare.com:article/24399754","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Dopamine_D2_and_D3_receptor_agonists_limit_oligodendrocyte_injury_caused_by_glutamate_oxidative_stress_and_oxygen_glucose_deprivation/24399754","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:irep.ntu.ac.uk:18772","doi":null,"is_oa":false,"landing_page_url":"http://irep.ntu.ac.uk/id/eprint/18772/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400559","display_name":"Nottingham Trent University's Institutional Repository (Nottingham Trent Repository)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I52590639","host_organization_name":"Nottingham Trent University","host_organization_lineage":["https://openalex.org/I52590639"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"},{"id":"mag:2605339365","doi":null,"is_oa":false,"landing_page_url":"http://irep.ntu.ac.uk/id/eprint/18772/","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:figshare.com:article/24399754","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Dopamine_D2_and_D3_receptor_agonists_limit_oligodendrocyte_injury_caused_by_glutamate_oxidative_stress_and_oxygen_glucose_deprivation/24399754","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320334629","display_name":"Biotechnology and Biological Sciences Research Council","ror":"https://ror.org/00cwqg982"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":60,"referenced_works":["https://openalex.org/W61725528","https://openalex.org/W116796221","https://openalex.org/W1440877385","https://openalex.org/W1512211793","https://openalex.org/W1525431558","https://openalex.org/W1725973209","https://openalex.org/W1891591278","https://openalex.org/W1925492557","https://openalex.org/W1947475203","https://openalex.org/W1959543927","https://openalex.org/W1963932280","https://openalex.org/W1966092598","https://openalex.org/W1968716671","https://openalex.org/W1971417227","https://openalex.org/W1972673753","https://openalex.org/W1993336124","https://openalex.org/W1993408885","https://openalex.org/W1993934642","https://openalex.org/W1998858609","https://openalex.org/W1998938785","https://openalex.org/W2000626734","https://openalex.org/W2001644602","https://openalex.org/W2007074501","https://openalex.org/W2008156619","https://openalex.org/W2016575029","https://openalex.org/W2016759315","https://openalex.org/W2017159332","https://openalex.org/W2017527267","https://openalex.org/W2017549779","https://openalex.org/W2024923637","https://openalex.org/W2025326971","https://openalex.org/W2029973048","https://openalex.org/W2030905853","https://openalex.org/W2035750459","https://openalex.org/W2041516981","https://openalex.org/W2053088210","https://openalex.org/W2059230444","https://openalex.org/W2061540554","https://openalex.org/W2062530699","https://openalex.org/W2071164093","https://openalex.org/W2076009972","https://openalex.org/W2077821351","https://openalex.org/W2077870714","https://openalex.org/W2083156858","https://openalex.org/W2084022990","https://openalex.org/W2086143711","https://openalex.org/W2094347708","https://openalex.org/W2097607289","https://openalex.org/W2100727635","https://openalex.org/W2112215110","https://openalex.org/W2119851678","https://openalex.org/W2132390812","https://openalex.org/W2135250775","https://openalex.org/W2137813387","https://openalex.org/W2142716454","https://openalex.org/W2150929583","https://openalex.org/W2154025261","https://openalex.org/W2169759040","https://openalex.org/W2170019144","https://openalex.org/W2401031259"],"related_works":["https://openalex.org/W1993336124","https://openalex.org/W2008156619","https://openalex.org/W956550471","https://openalex.org/W2064298450","https://openalex.org/W4361282871","https://openalex.org/W2089824848","https://openalex.org/W2060199887","https://openalex.org/W2122259129","https://openalex.org/W3201761665"],"abstract_inverted_index":{"Dopamine":[0],"receptor":[1,26,71,74,121,124,148],"activation":[2,149],"is":[3],"thought":[4],"to":[5,8,30,79,84,132],"contribute":[6],"adversely":[7],"several":[9],"neuropathological":[10],"disorders,":[11],"including":[12],"Parkinson's":[13],"disease":[14],"and":[15,72,83,92,106,114,122,137,146,162],"schizophrenia.":[16],"In":[17],"addition,":[18],"dopamine":[19,25,69,90,144],"may":[20,150],"have":[21],"a":[22,52],"neuroprotective":[23],"role:":[24],"agonists":[27],"are":[28],"reported":[29],"protect":[31],"nerve":[32],"cells":[33],"by":[34,43,112,128],"virtue":[35],"of":[36,98,104,118],"their":[37],"antioxidant":[38],"properties":[39],"as":[40,42,126],"well":[41],"receptor-mediated":[44],"mechanisms.":[45],"White":[46],"matter":[47],"injury":[48],"can":[49],"also":[50],"be":[51],"significant":[53,96],"factor":[54],"in":[55,155],"neurological":[56],"disorders.":[57],"Using":[58],"real-time":[59],"RT-PCR,":[60],"we":[61],"show":[62],"that":[63,143],"differentiated":[64],"rat":[65],"cortical":[66],"oligodendrocytes":[67,99],"express":[68],"D2":[70,91,113,120,145],"D3":[73,93,115,123,147],"mRNA.":[75],"Oligodendrocytes":[76],"were":[77],"vulnerable":[78],"oxidative":[80,159],"glutamate":[81,160],"toxicity":[82,161],"oxygen/glucose":[85],"deprivation":[86,164],"injury.":[87,165],"Agonists":[88],"for":[89],"receptors":[94],"provided":[95],"protection":[97,157],"against":[100,158],"these":[101],"two":[102],"forms":[103],"injury,":[105],"the":[107],"protective":[108],"effect":[109],"was":[110],"diminished":[111],"antagonists.":[116],"Levels":[117],"oligodendrocyte":[119,156],"protein,":[125],"measured":[127],"Western":[129],"blotting,":[130],"appeared":[131],"increase":[133],"following":[134],"combined":[135],"oxygen":[136],"glucose":[138],"deprivation.":[139],"Our":[140],"results":[141],"suggest":[142],"play":[151],"an":[152],"important":[153],"role":[154],"oxygen-glucose":[163]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2012171192","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":7},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
